Journals / Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi / 2012 / Cilt: 9 - Sayı: 36

Ovulation induction and controlled ovarian hyperstimulation: A global perspectİve

Ovulasyon indüksiyonu ve kontrollü ovaryan hiperstimülasyona genel bakış

Pages
1509–1517
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we will summarize the ovulation induction and controlled ovarian hyperstimulation protocols and present the new literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Infertility which is defined as inability to conceive in one year after unprotected regular intercourse, is a common medical but also a serious economic and social problem affecting almost 15% of the couples.
📊
Key Findings & Data:The tremendous growth in medical industry in the last 20 years led to the development of new agents to join in ovulation induction and controlled ovarian hyperstimulation protocols and enables the clinician to develop new protocols which are more cost effective and patient friendly.
💡
Conclusion & Impact:In this review, we will summarize the ovulation induction and controlled ovarian hyperstimulation protocols and present the new literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Infertility which is defined as inability to conceive in one year after unprotected regular intercourse, is a common medical but also a serious economic and social problem affecting almost 15% of the couples. The tremendous growth in medical industry in the last 20 years led to the development of new agents to join in ovulation induction and controlled ovarian hyperstimulation protocols and enables the clinician to develop new protocols which are more cost effective and patient friendly. In this review, we will summarize the ovulation induction and controlled ovarian hyperstimulation protocols and present the new literature.

Özet

Bir yıllık korunmasız ilişkiye rağmen gebeliğin oluşmaması olarak tanımlanan ve çiftlerin yaklaşık %15ini etkileyen infertilite, medikal bir problem olduğu kadar sosyal ve ekonomik yönden de önemli bir yük olarak karşımıza çıkmaktadır. İnfertilite tedavisinde kullanılan ilaçlarda özellikle son 20 yılda gözlenen hızlı gelişim ovulasyon indüksiyonu ve kontrollü ovaryan hiperstimülasyon protokollerine yeni ajanların katılıp, gerek maliyet gerekse hasta dostu yaklaşım açısından klinisyenlere farklı seçenekler sunmaya olanak sağlamıştır. Aşağıdaki derlemede, ovulasyon indüksiyonu ve kontrollü ovaryan hiperstimülasyon protokolleri özetlenecek ve literatürdeki yeni gelişmeler sunulacaktır.

🔖

Cite This Article

YILMAZ, N., KAHYAOĞLU, İ. (2022). Ovulation induction and controlled ovarian hyperstimulation: A global perspectİve. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, Cilt: 9 - Sayı: 36, 1509–1517. https://ajindex.com/articles/558957

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Hull MG, Glazener CM, Kelly NJ, Conway DI, Foster PA, Hinton RA, Coulson C, Lambert PA, Watt EM, Desai KM. Population study of causes, treatment, and outcome of infertility.Br Med J (Clin Res Ed). 1985;291(6510):1693
  2. Collins JA, Hughes EG Pharmacological interventions for the induction of ovulation. Drugs. 1995 Sep;50(3):480-94. Review 3. Laven JS, Imani B, Eijkemans MJ, Fauser BC. New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv. 2002;57(11):755
  3. Practice Committee of the American Society for Reproductive Medicine.Use of clomiphene citrate in women. Fertil Steril. 2006 Nov;86(5 Suppl 1):S187-93. Review
  4. Clark JH, Markaverich BM.The agonistic-antagonistic properties of clomiphene: a review. Pharmacol Ther. 1981;15(3):467-519
  5. Mikkelson TJ, Kroboth PD, Cameron WJ, Dittert LW, Chungi V, Manberg PJ. Single-dose pharmacokinetics of clomiphene citrate in normal volunteers.Fertil Steril. 1986 Sep;46(3):392-6 7. Van Campenhout J, Borreman E, Wyman H, Antaki A.Induction of ovulation with cisclomiphene. Am J Obstet Gynecol. 1973 Feb 1;115(3):321-7
  6. Young SL, Opsahl MS, Fritz MA. Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women.Fertil Steril. 1999 Apr;71(4):639-44 9. Kerin JF, Liu JH, Phillipou G, Yen SS. Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab. 1985 Aug;61(2):265-8 10. Kettel LM, Roseff SJ, Berga SL, Mortola JF, Yen SS. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome. Fertil Steril. 1993 Mar;59(3):532-8 11. Jorgensen SE, Starup J, Roos J, Micic S. Studies on the mode of action of clomiphene citrate. Acta Obstet Gynecol Scand. 1976;55(4):337-40
  7. Dehbashi S, Parsanezhad ME, Alborzi S, Zarei A. Effect of clomiphene citrate on endometrium thickness and echogenic patterns. Int J Gynaecol Obstet. 2003;80(1):49 13. Bonhoff AJ, Naether OG, Johannisson E. Effects of clomiphene citrate stimulation on endometrial structure in infertile women. Hum Reprod. 1996;11(4):844
  8. Sereepapong W, Suwajanakorn S, Triratanachat S, Sampatanukul P, Pruksananonda K, Boonkasemsanti W, Reinprayoon D Effects of clomiphene citrate on the endometrium of regularly cycling women. Fertil Steril. 2000;73(2):287
  9. Goldstein SR, Siddhanti S, Ciaccia AV, Plouffe L Jr. A pharmacological review of selective oestrogen re